Xenon Pharmaceuticals (XENE) Tops Q1 EPS by 6c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. RNG
2. DECK
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Xenon Pharmaceuticals (XENE) Tops Q1 EPS by 6c

Xenon Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate Update

May 10, 2022 4:01 PM EDT

XEN1101 End of Phase 2 Meeting with FDA to take Place in Second Quarter and Initiation of Phase 3 in Adult Focal Epilepsy Expected in the Second Half of 2022

Company-sponsored Phase 2 Clinical Trial Initiated to Evaluate XEN1101 for the Treatment of MDD

Conference Call at 4:30 pm ET Today

BURNABY, British Columbia, May 10, 2022 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals... More